Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

J&J to submit at least 10 medicines for approval by 2019

U.S. healthcare conglomerate Johnson & Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of the experimental drug daratumumab for […]

Read More »

Novo Nordisk rejects Baxter patent claim over Novoeight

Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that it had infringed patents on drugs to treat the bleeding disorder hemophilia, the Danish company said on Wednesday. Baxter had said Novo Nordisk’s newly launched hemophilia drug Novoeight infringed some of its patents, prompting an investigation from the U.S. International Trade […]

Read More »

Four U.S. cancer charities charged; two settle

The U.S. government has charged four cancer charities with misusing more than $187 million in donations, with two agreeing to be dissolved and two fighting the allegations, the Federal Trade Commission said on Tuesday. The FTC, 50 states and the District of Columbia charged the Cancer Fund of America, Cancer Support Services Inc, the Children’s […]

Read More »

Lpath to cut jobs as eye drug fails mid-stage study; shares fall

Drug developer Lpath Inc said it would cut jobs and costs after its experimental eye drug failed a mid-stage study in patients with wet age-related macular degeneration, a leading cause of blindness in the elderly. The biotechnology company’s shares fell nearly 71 percent to $0.50 in premarket trading on Wednesday. Lpath, which had about 25 […]

Read More »

Amputees control bionic legs with their thoughts

Amputees can control their bionic prosthetic limbs with their minds, thanks to tiny implanted myoelectric sensors (IMES) developed by Icelandic orthopedics company Ossur and surgically placed in a patient’s residual muscle tissue.  Ossur implanted tiny sensors in the residual muscle tissue of two amputees that they say trigger movement in the prosthesis via a receiver. […]

Read More »

Drinking Coffee May Lower Erectile Dysfunction Risk, University of Houston Study

Caffeine Intake Associated With Reduced Levels Of Erectile Dysfunction HOUSTON – (May 20, 2015) – Men who drink the equivalent caffeine level of two to three cups of coffee a day are less likely to have erectile dysfunction (ED), according to researchers from The University of Texas Health Science Center at Houston (UTHealth). The results […]

Read More »

New Data Analyses on Investigational Tiotropium/Olodaterol Respimat Showed Greater Lung Function Improvement Compared to Tiotropium and Olodaterol Alone

DENVER, May 20, 2015 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced new data analyses from the pivotal Phase III TONADO™ 1&2 studies (NCT01431274/NCT01431287), which explored the efficacy and safety of investigational tiotropium/olodaterol delivered via the Respimat® inhaler for chronic obstructive pulmonary disease (COPD) compared to the individual components (tiotropium and olodaterol delivered by the […]

Read More »

Four New Mumps Cases Diagnosed In Outbreak At University of Texas at Austin

Another four cases of mumps were diagnosed on the campus of the University of Texas at Austin, bringing the total number of cases in the university outbreak to seven. The Travis County Health Department notified the University of the four new cases yesterday afternoon. The first case in the outbreak was diagnosed May 6 following […]

Read More »

Orexigen CEO Pledged To Keep Data Secret, But Not From Himself

In an interview two years ago, Orexigen Chief Executive Mike Narachi understood that data from the largest clinical trial of his company’s weight loss drug Contrave were to be kept secret except for “a small team” that would use it to file for approval with the Food and Drug Administration. However, Narachi differed from CEOs […]

Read More »

J&J Pegs Its Long-Term Growth Potential On Prevention

During Johnson & Johnson’s Pharmaceutical Business Review Wednesday, several executives from the healthcare-products giant made a case to Wall Street analysts that its pipeline of new drugs is strong enough to drive strong short-term sales and profit growth. But behind the scenes, the company is making a huge bet that focusing on disease prevention will […]

Read More »

Do R&D Costs Matter When It Comes To Drug Pricing?

Dr. Jerry Avorn, of Harvard Medical School and a long-time critic of the pharmaceutical industry, has published an opinion piece in the New England Journal of Medicine, challenging the costs of drug R&D as elucidated by the Tufts Center for the Study of Drug Development. Last November, the Tufts group published an analysis showing that […]

Read More »

New ‘Microneedle Pill’ Could Replace Syringes For Injectable Medications

What’s more appealing: getting a shot, or swallowing a pill full of needles? The lesser of those two evils may seem obvious, but a new invention may soon cause you to second-guess that preference. 28-year-old Carl Schoellhammer, a chemical engineering graduate student at MIT, doesn’t have a high opinion of shots. “They’re horrible, they’re painful, […]

Read More »

DIA Annual Meeting to Address Future Innovation and Integrated Approach to Advance the Development of Health Care Products

WASHINGTON–(BUSINESS WIRE)–Sessions at the DIA 2015 51st Annual Meeting will bring together individuals across all disciplines in the discovery, development, and life cycle management of health care products with a goal of fostering innovation that will lead to the development of safe and effective medical products and therapies. The Annual Meeting will be held at […]

Read More »

Gilead patents on costly hepatitis C drug challenged in five countries

 A U.S. group is trying to block patents in five countries for Gilead Sciences Inc’s costly hepatitis C drug Sovaldi, in a bid to give almost 60 million afflicted people access to cheaper generic versions. In Argentina, Brazil, China, Russia and Ukraine, challenges have been filed against Gilead’s patents or patent applications, the New York-based […]

Read More »

Re-engineered antibiotic shows potential for treatment of drug-resistant bacteria

MEMPHIS, Tenn., May 20, 2015 /PRNewswire-USNewswire/ — Researchers led by St. Jude Children’s Research Hospital scientists have developed a second-generation antibiotic that shows early effectiveness against common bacterial infections that pose a serious health threat to children and adults. The findings appear today in the scientific journal Science Translational Medicine. The study marks the second time […]

Read More »

Most Americans still don’t use sunscreen

(Reuters Health) – Despite years of public health messages, barely one third of Americans use sunscreen regularly, according to the U.S. Centers for Disease Control and Prevention (CDC). Researchers found that sunscreen is most often used by women on the skin of the face, and by people with higher household income. The cost of sunscreen […]

Read More »

Actress Kristen Bell and Los Angeles OBGYN Howie Mandel Honored for Commitment to Improving Health of Women Worldwide

LOS ANGELES, May 20, 2015 /PRNewswire-USNewswire/ — Jhpiego, an international health care non-profit and affiliate of Johns Hopkins University, honored actress-activist Kristen Bell and Los Angeles physician Howie Mandel for their selfless dedication to preventing the needless deaths of women and families worldwide. Celebrities from across the TV and movie industry attended the “Laughter Is […]

Read More »

Earlier Puberty And Stunted Growth In Boys Linked To Marijuana Use, Study

Marijuana is the most commonly used illicit drug in the US – particularly among adolescents and young adults. According to the National Institute on Drug Abuse, a 2014 survey revealed that 11.7% of 8th graders reported using marijuana in the past year, with 6.5% of these reporting current use of the drug. Numerous studies have […]

Read More »

Scripps Health Offers Insights Into Nation’s First All Pencil-Beam Proton Center

SAN DIEGO, May 20, 2015 /PRNewswire/ — The nation’s first and only proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care just more than a year ago. Carl Rossi, M.D., medical director of the Scripps Proton Therapy Center in San Diego, […]

Read More »

World’s Most Expensive Medicine: Is it Worth It?

Is it worth $1 million to treat a potentially fatal genetic disease that causes painful swelling of the pancreas and can require repeated trips to the emergency room? Germany says it’s not sure. Health authorities there ruled Thursday that the benefit of Glybera, the first gene therapy approved for use in Europe, is “not quantifiable” […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom